2026 · Clinical chemistry and laboratory medicine · paywalled
Diagnostic accuracy of dried blood spot samples for hepatitis B diagnosis: a systematic review and meta-analysis
Wang et al.
The finding, in our words
Dried blood spot testing achieved high diagnostic accuracy for hepatitis B surface antigen (sensitivity 94.3%, specificity 98.8%), supporting its use in decentralised screening and resource-limited settings. However, sensitivity was lower for anti-HBc (83.6%) and HBV DNA (86.9%) tests, though specificity remained high for both, indicating need for further standardisation.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
The study validated a semi-quantitative protocol for Epstein-Barr virus serology using dried blood spots, demonstrating 98.8% sensitivity and 96.5% specificity compared to paired venous serum samples. The successful validation in a self-sampling cohort confirms the suitability of this patient-centric microsampling approach for large-scale seroprevalence studies and decentralised trials.
Capillary samples collected using dried blood spots and Mitra microsamplers showed strong agreement with venous plasma for quantifying IgG antibodies against most vaccine-preventable diseases. Sensitivity was high for the majority of pathogens, though the study noted that antibody stability declined at room temperature over time, favouring cold storage for longer durations.
Ombati et al., Scientific reports (paywalled) · source ↗
A 2025 review maps 28 microsampling devices, from dried spots and volumetric absorptive tips to upper-arm liquid capillary collectors, and names what a laboratory must control before their results are used: the haematocrit effect in non-volumetric dried samples, interstitial fluid from finger milking, volume, haemolysis and transport stability. Regulators on both sides of the Atlantic ask for the same two things, a device the patient can use safely and a sample fit for the test.
The review found dried blood spot sampling correlates strongly with plasma for HIV-1 viral load and offers simplified collection, transport and storage without cold-chain. This could expand access to monitoring in resource-limited settings and improve clinical outcomes through earlier detection of treatment failure.
Self-collected dried blood spots analysed on the Roche Elecsys platform gave quantitative anti-spike antibody results that agreed closely with paired venous samples, with sensitivity 96.63% and specificity 97.81% and a conversion formula across 0.018 to 250 U/mL, enabling accurate tracking of titre changes in longitudinal cohorts after vaccination.
Castelletti et al., Microbiology spectrum · source ↗